Press Releases
- Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting September 12, 2014 14:00 (CEST)
- Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease August 14, 2014 08:36 (CEST)
- Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease August 14, 2014 08:30 (CEST)
- Active Biotech AB Interim report January-June 2014 August 7, 2014 08:36 (CEST)
- Active Biotech AB Interim report January-June 2014 August 7, 2014 08:30 (CEST)
- Active Biotech presents data on paquinimod at EULAR 2014 June 11, 2014 08:36 (CEST)
- Active Biotech presents data on paquinimod at EULAR 2014 June 11, 2014 08:30 (CEST)
- Active Biotech to Present at Jefferies 2014 Healthcare Conference June 3, 2014 08:35 (CEST)
- Active Biotech to Present at Jefferies 2014 Healthcare Conference June 3, 2014 08:30 (CEST)
- Teva and Active Biotech to continue with the development of NERVENTRA® (laquinimod) for multiple sclerosis following confirmation of CHMP opinion May 23, 2014 08:30 (CEST)